Stephen Johnson

Array ( [id] => 9318441 [patent_doc_number] => 20140050779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-20 [patent_title] => 'TRANSGLUTAMINASE-2 INHIBITORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/984508 [patent_app_country] => US [patent_app_date] => 2012-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 17283 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13984508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8228441 [patent_doc_number] => 20120142652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'COMPOSITIONS AND METHODS FOR LOCALIZED THERAPY OF THE EYE' [patent_app_type] => utility [patent_app_number] => 13/367070 [patent_app_country] => US [patent_app_date] => 2012-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7252 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13367070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8186601 [patent_doc_number] => 20120115829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'Low Viscosity, Highly Flocculated Triamcinolone Acetonide Suspensions for Intravitreal Injection' [patent_app_type] => utility [patent_app_number] => 13/352043 [patent_app_country] => US [patent_app_date] => 2012-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4353 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115829.pdf [firstpage_image] =>[orig_patent_app_number] => 13352043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8270377 [patent_doc_number] => 08211880 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection' [patent_app_type] => utility [patent_app_number] => 13/352009 [patent_app_country] => US [patent_app_date] => 2012-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4378 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13352009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199316 [patent_doc_number] => 20120122815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'Composition for Treating Dry Eye and Related Methods of Manufacture and Methods of Use' [patent_app_type] => utility [patent_app_number] => 13/347725 [patent_app_country] => US [patent_app_date] => 2012-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4992 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122815.pdf [firstpage_image] =>[orig_patent_app_number] => 13347725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8371164 [patent_doc_number] => 20120220554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'Combretastatins for Prevention of Posterior Capsule Opacification' [patent_app_type] => utility [patent_app_number] => 13/342158 [patent_app_country] => US [patent_app_date] => 2012-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15461 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13342158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10044408 [patent_doc_number] => 09084791 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-21 [patent_title] => 'Method of inhibiting myopia and application of an adenylyl cyclase inhibitor as a drug for inhibiting myopia' [patent_app_type] => utility [patent_app_number] => 13/513098 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1337 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13513098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8469946 [patent_doc_number] => 08299124 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => 'Aqueous intraocular penetration-promoting eye drop' [patent_app_type] => utility [patent_app_number] => 13/332827 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7977 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13332827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8690013 [patent_doc_number] => 08389542 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Dosage unit comprising a prostaglandin analog for treating constipation' [patent_app_type] => utility [patent_app_number] => 13/330942 [patent_app_country] => US [patent_app_date] => 2011-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4629 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13330942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8140989 [patent_doc_number] => 20120095050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'STABILIZED AND PRESERVED KETOTIFEN OPHTHALMIC COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/330992 [patent_app_country] => US [patent_app_date] => 2011-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6039 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20120095050.pdf [firstpage_image] =>[orig_patent_app_number] => 13330992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8043515 [patent_doc_number] => 20120071485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'Therapeutic Compositions And Methods' [patent_app_type] => utility [patent_app_number] => 13/304116 [patent_app_country] => US [patent_app_date] => 2011-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 19198 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071485.pdf [firstpage_image] =>[orig_patent_app_number] => 13304116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8186976 [patent_doc_number] => 20120115959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'Therapeutic Compositions And Methods' [patent_app_type] => utility [patent_app_number] => 13/304088 [patent_app_country] => US [patent_app_date] => 2011-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19197 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115959.pdf [firstpage_image] =>[orig_patent_app_number] => 13304088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8624885 [patent_doc_number] => 08357379 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-22 [patent_title] => 'High concentration baclofen preparations' [patent_app_type] => utility [patent_app_number] => 13/300109 [patent_app_country] => US [patent_app_date] => 2011-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7121 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13300109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8228459 [patent_doc_number] => 20120142675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'Methods for Treating Diseases of the Retina' [patent_app_type] => utility [patent_app_number] => 13/298028 [patent_app_country] => US [patent_app_date] => 2011-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4736 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13298028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8265952 [patent_doc_number] => 20120165383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'INFLAMMATORY EYE DISEASE' [patent_app_type] => utility [patent_app_number] => 13/293748 [patent_app_country] => US [patent_app_date] => 2011-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7409 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13293748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12085926 [patent_doc_number] => 09839640 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-12 [patent_title] => 'Methods of treating eye diseases associated with inflammation and vascular proliferation' [patent_app_type] => utility [patent_app_number] => 13/989677 [patent_app_country] => US [patent_app_date] => 2011-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19507 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13989677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8211378 [patent_doc_number] => 20120129847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 13/253397 [patent_app_country] => US [patent_app_date] => 2011-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 58579 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129847.pdf [firstpage_image] =>[orig_patent_app_number] => 13253397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733623 [patent_doc_number] => 20120015971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'OPHTHALMIC COMPOSITION COMPRISING ASCOMYCIN' [patent_app_type] => utility [patent_app_number] => 13/241340 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3447 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015971.pdf [firstpage_image] =>[orig_patent_app_number] => 13241340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7767945 [patent_doc_number] => 20120035148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC CONDITIONS' [patent_app_type] => utility [patent_app_number] => 13/236432 [patent_app_country] => US [patent_app_date] => 2011-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5618 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035148.pdf [firstpage_image] =>[orig_patent_app_number] => 13236432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8956022 [patent_doc_number] => 08501796 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-06 [patent_title] => 'Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for lowering intraocular pressure' [patent_app_type] => utility [patent_app_number] => 13/233844 [patent_app_country] => US [patent_app_date] => 2011-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10535 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13233844 [rel_patent_id] =>[rel_patent_doc_number] =>)